Tata Capital in the news

Resona Bank invested $20 million in Tata Capital's fund and partnered with Tata Capital to support Japanese companies expanding into India.

Tata Capital launched a digital film campaign '#CountOnTheBond' for Raksha Bandhan, showcasing mutual sibling support through everyday actions.

Tata Capital launched a Raksha Bandhan campaign, "#CountOnTheBond", celebrating the understated mutual support between siblings through a film about a brother and sister.

Japan's Resona Bank has partnered with Tata Capital and invested $20 million in its growth fund to enhance access to financing and opportunities in India for its clients.

Tata Capital Housing is accepting bids for its 5-year bonds.

Tenet Diagnostics secured $30 million in funding from Tata Capital Healthcare Fund III and Blue Earth Capital to expand its diagnostic services across India.

Tata Capital Healthcare Fund and Blue Earth Capital invested $30 million in Tenet Diagnostics to fuel its expansion across India.

Tata Capital is discussing a proposed RBI ban on revolving credit facilities, reporting less than 5% exposure to such loans.

JSW Realty is negotiating a 16-billion rupee loan from Tata Capital Ltd.

Tata Capital is hiring a legal senior manager specialized in corporate litigation and debt recovery for its SME and commercial finance divisions.

The Bombay High Court has moved a 36.10 crore INR loan default case involving Tata Capital into arbitration to expedite the recovery process.

Tata Capital financed a 1,250 crore loan for Inox Clean Energy to fund renewable energy acquisitions and corporate expansion.

Tata Capital provided INR 1,250 crore in financing to Inox Clean Energy Services for renewable energy operations.

Shareholders have overwhelmingly approved Tata Capital's material related party transactions with Tata Steel.

Valuation multiples for the firm have reached premium levels, triggering a rating downgrade to Sell amid modest return metrics and recent stock underperformance.

Tata Capital targets 23-25% annual growth by prioritizing housing finance, SME lending, and secured retail sectors while maintaining asset quality.

Tata Capital reported a 42.82% surge in quarterly net profit and strong annual revenue growth for the period ending March 2026.

Regulatory pressure for a Tata Sons IPO threatens the conglomerate's long-term investment flexibility and faces strong internal resistance.

Anderson Diagnostics is raising INR 250 Cr with support from Tata Capital Healthcare Fund to expand its diagnostic and genomic services.

Tata Capital faces a bearish technical shift and a rating downgrade to Sell due to weakening momentum and poor volume trends.